Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP4124093B2 - Method for producing a composition for oral taste preparation - Google Patents
[go: Go Back, main page]

JP4124093B2 - Method for producing a composition for oral taste preparation - Google Patents

Method for producing a composition for oral taste preparation Download PDF

Info

Publication number
JP4124093B2
JP4124093B2 JP2003360295A JP2003360295A JP4124093B2 JP 4124093 B2 JP4124093 B2 JP 4124093B2 JP 2003360295 A JP2003360295 A JP 2003360295A JP 2003360295 A JP2003360295 A JP 2003360295A JP 4124093 B2 JP4124093 B2 JP 4124093B2
Authority
JP
Japan
Prior art keywords
composition
syrup
sugar
taste
granulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2003360295A
Other languages
Japanese (ja)
Other versions
JP2004083595A (en
Inventor
卓 水谷
昭彦 岡本
孝 山崎
洋 中野
正人 高橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority to JP2003360295A priority Critical patent/JP4124093B2/en
Publication of JP2004083595A publication Critical patent/JP2004083595A/en
Application granted granted Critical
Publication of JP4124093B2 publication Critical patent/JP4124093B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Description

本発明は、苦味や渋味を有する成分を配合した経口製剤用組成物の製造方法に関する。 The present invention relates to a method for producing a composition for oral preparations containing ingredients having bitterness and astringency.

顆粒剤、散剤、錠剤といった造粒物を用いた製剤を製する際、その多くは湿式造粒法で行われている。湿式造粒法には主として押出造粒法、破砕造粒法、転動造粒法、並びに流動層造粒法の4種類が用いられるが、いずれも原料成分は必要に応じて粉砕され、混合し、造粒を行っている。
したがって、苦味や渋味を有する成分を配合した造粒物を製する場合には、これらの造粒法のみでは表面に成分が露出しているため、風味が悪く、製剤的に不適当であった。
When producing a preparation using a granulated material such as a granule, a powder, or a tablet, most of them are performed by a wet granulation method. There are mainly four types of wet granulation methods: extrusion granulation method, crushing granulation method, rolling granulation method, and fluidized bed granulation method. In any case, the raw material components are ground and mixed as necessary. And granulating.
Therefore, when producing a granulated product containing ingredients having bitterness and astringency, the ingredients are exposed on the surface only by these granulation methods, so the taste is poor and the formulation is inappropriate. It was.

上記課題に際しては、造粒物の表面をコーティングすることで苦味や渋味のマスキングが可能になるが、より好ましくは、甘味のあるもの、矯味効果を有するものをコーティングに用いることである。甘味や矯味効果の強いものほど苦味や渋味のマスキングには適しており、その効果が強いものとしては砂糖を挙げることができる。湿式造粒法で造粒する際にこの水溶液すなわちシロップを用いることでその効果が最大限に発揮されるものと期待される。
しかしながら、シロップを用いて湿式造粒法で造粒する場合、方法によっては造粒物の表面に成分が現れることがあるため、苦味や渋味が発現し、また、ざらつき感がある、といった服用感の問題が生じる。さらに、シロップの濃度によっては作業性が著しく劣るものとなる。
In the above-mentioned problem, the surface of the granulated product can be coated to mask bitterness and astringency, but more preferably, a sweet thing or a substance having a taste-masking effect is used for coating. The stronger the sweet taste and taste-masking effect, the more suitable for masking bitterness and astringency, and sugar can be mentioned as the stronger effect. By using this aqueous solution, that is, syrup, when the granulation is performed by the wet granulation method, it is expected that the effect will be maximized.
However, when granulation is performed by wet granulation using syrup, depending on the method, ingredients may appear on the surface of the granulated product, so that bitterness and astringency appear, and there is a feeling of roughness The problem of feeling arises. Furthermore, workability is remarkably inferior depending on the concentration of syrup.

糖衣顆粒を製造する方法としてシロップを用いて造粒する技術が開示されている(特許文献1)。しかし、これは造粒した後に糖衣コーティングをするため、作業工程が多く、煩雑である。また、砂糖でできた球形顆粒(ノンパレル)に、シロップを糊剤として、薬物と共に流動層造粒する技術が開示されている(特許文献2)。しかし、この方法で製造された顆粒は、服用した際にザラツキを感じ、服用感の良い製剤を製造できない。
特開昭52-151717号公報 特開昭62-15号公報
A technique for granulating using syrup is disclosed as a method for producing sugar-coated granules (Patent Document 1). However, since this is coated with sugar coating after granulation, there are many work steps and it is complicated. In addition, a technique of fluidized bed granulation with a drug using syrup as a paste on spherical granules (non-parrel) made of sugar is disclosed (Patent Document 2). However, the granule produced by this method feels rough when taken, and it is impossible to produce a preparation with good taking feeling.
Japanese Patent Laid-Open No. 52-151717 Japanese Patent Laid-Open No. Sho 62-15

本発明の目的は、シロップを用いた場合であっても作業性が良く、服用性に優れた矯味経口製剤用組成物の製造方法を提供することである。   An object of the present invention is to provide a method for producing a composition for a taste-masked oral preparation, which has good workability even when syrup is used, and is excellent in dosing.

そこで本発明者らは上記課題を解決すべく鋭意検討を行った結果、流動層造粒機を用い、造粒時に特定濃度のシロップを噴霧する方法が、服用感を向上させる経口製剤用組成物の製造に適していることを見いだし、本発明を完成した。
すなわち本発明は、苦味や渋味を有する薬物、及び粉糖を含む粉体組成物を、砂糖濃度が50〜60%のシロップを用いて流動層造粒法で造粒することを特徴とする矯味経口製剤用組成物の製造方法である。
Therefore, as a result of intensive studies to solve the above problems, the present inventors have used a fluidized bed granulator, and the method of spraying a specific concentration of syrup during granulation improves the dosage feeling. The present invention has been found to be suitable for the production of the present invention.
That is, the present invention is characterized by granulating a powder composition containing a drug having a bitter taste or astringency and powdered sugar by a fluidized bed granulation method using a syrup having a sugar concentration of 50 to 60%. It is a manufacturing method of the composition for taste-masking oral preparations.

本発明は、製造時の作業性が優れ、かつ服用感の良好な矯味経口製剤用組成物を提供することができる。   INDUSTRIAL APPLICABILITY The present invention can provide a composition for taste-masked oral preparations that is excellent in workability during production and has a good feeling of taking.

本発明に用いるシロップの量は、組成物当り砂糖として10〜50重量部が好ましい。このシロップの濃度及び量で味覚的に不足する砂糖については、造粒前の粉体に砂糖を配合することで補うことができるが、砂糖をそのまま用いると造粒時の作業性が低下するうえ、服用時にざらつき感を生じるため、砂糖を微粉砕化した粉糖を用いることが好ましい。粉糖の配合量は組成物当り20〜80重量部が好ましいが、十分に矯味効果を発揮する量であり、かつ製剤学的に許容できる範囲内であればよい。   The amount of syrup used in the present invention is preferably 10 to 50 parts by weight as sugar per composition. The sugar that is tastefully lacking in the concentration and amount of syrup can be compensated by adding sugar to the powder before granulation. It is preferable to use powdered sugar obtained by pulverizing sugar in order to produce a rough feeling when taken. The blending amount of powdered sugar is preferably 20 to 80 parts by weight per composition, but may be an amount that sufficiently exhibits a taste-masking effect and within a pharmaceutically acceptable range.

本発明の製造方法より得られる経口製剤用組成物に配合する苦味や渋味を有する薬物としては、硝酸チアミンなどのビタミンB1 類、リボフラビンなどのビタミンB2 類、塩酸ピリドキシンなどのビタミンB6 類等が挙げられる。これらの薬物の配合量は、その味の強度により相違するが、硝酸チアミンやリボフラビンなどの場合、組成物当り0.01〜10重量部が好ましい。この範囲より多量では薬物の味が発現するため不適当である。   Examples of drugs having a bitter or astringent taste blended in the composition for oral preparation obtained from the production method of the present invention include vitamin B1 such as thiamine nitrate, vitamin B2 such as riboflavin, and vitamin B6 such as pyridoxine hydrochloride. Can be mentioned. The compounding amount of these drugs varies depending on the strength of the taste, but in the case of thiamine nitrate, riboflavin, etc., 0.01 to 10 parts by weight per composition is preferable. Larger amounts than this range are inappropriate because the taste of the drug is expressed.

本発明より得られる経口製剤用組成物には、上述した成分に加え、苦味や渋味を有しない他の薬物や、賦形剤、結合剤、崩壊剤、滑沢剤、着色剤、矯味剤等を配合することができる。苦味や渋味を有しない薬物としては、他のビタミン類やミネラル類などを挙げることができる。賦形剤としては、乳糖、デンプン類、結晶セルロース、タルク、砂糖、マンニトール、軽質無水ケイ酸、リン酸水素カルシウムなどが挙げられる。結合剤としては、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、ゼラチン、アルファー化デンプン、ポリビニルピロリドン、プルランなどが挙げられる。崩壊剤としては、低置換度ヒドロキシプロピルセルロース、カルメロースカルシウム、クロスカルメロースナトリウムなどが挙げられる。滑沢剤としてはステアリン酸マグネシウム、ステアリン酸カルシウムなどが挙げられる。着色剤としては、タール色素、ベンガラなどが挙げられる。矯味剤としては、ステビア、アスパルテーム、クエン酸、香料などが挙げられる。   In addition to the components described above, the composition for oral preparations obtained from the present invention includes other drugs that do not have bitterness or astringency, excipients, binders, disintegrants, lubricants, colorants, and flavoring agents. Etc. can be blended. Examples of drugs having no bitterness or astringency include other vitamins and minerals. Examples of the excipient include lactose, starches, crystalline cellulose, talc, sugar, mannitol, light anhydrous silicic acid, calcium hydrogen phosphate and the like. Examples of the binder include hydroxypropylcellulose, hydroxypropylmethylcellulose, gelatin, pregelatinized starch, polyvinylpyrrolidone, pullulan and the like. Examples of the disintegrant include low-substituted hydroxypropylcellulose, carmellose calcium, and croscarmellose sodium. Examples of the lubricant include magnesium stearate and calcium stearate. Examples of the colorant include tar pigments and bengara. Examples of the corrigent include stevia, aspartame, citric acid, and fragrance.

これらの各成分をそれぞれ混合、粉砕し、この粉砕物を流動層造粒機に入れ、砂糖濃度50〜60%のシロップを噴霧して造粒し、乾燥することで目的とする組成物を得ることができる。
本発明より得られる経口製剤用組成物は、そのまま顆粒剤、散剤として使用できるほか、打錠することで錠剤としても製剤化が可能である。
Each of these components is mixed and pulverized, the pulverized product is put into a fluidized bed granulator, syrup having a sugar concentration of 50 to 60% is sprayed, granulated, and dried to obtain a desired composition. be able to.
The composition for oral preparation obtained from the present invention can be used as a granule or powder as it is, and can also be formulated as a tablet by tableting.

以下、実施例及び試験例を挙げて本発明を具体的に説明する。
実施例1 硝酸チアミン4g、リボフラビン2g、粉糖1200g、バレイショデンプン94g、ヒドロキシプロピルセルロース200gを混合、粉砕する。この粉砕物を流動層造粒機に入れ、50%のシロップ1000gを噴霧して造粒を行い、これを乾燥して目的とする組成物2000gを得た。
比較例1 実施例1において造粒機を撹拌造粒機とした他は同様にして、組成物を得た。
比較例2 実施例1においてシロップの砂糖濃度を30%とした他は同様にして、組成物を得た。
比較例3 実施例1においてシロップの砂糖濃度を70%とした他は同様にして、組成物を得た。
Hereinafter, the present invention will be specifically described with reference to Examples and Test Examples.
Example 1 4 g of thiamine nitrate, 2 g of riboflavin, 1200 g of powdered sugar, 94 g of potato starch and 200 g of hydroxypropylcellulose are mixed and pulverized. This pulverized product was put in a fluidized bed granulator, granulated by spraying 1000 g of 50% syrup, and dried to obtain 2000 g of the intended composition.
Comparative Example 1 A composition was obtained in the same manner as in Example 1 except that the granulator was a stirring granulator.
Comparative Example 2 A composition was obtained in the same manner as in Example 1 except that the sugar concentration of syrup was 30%.
Comparative Example 3 A composition was obtained in the same manner as in Example 1 except that the sugar concentration of syrup was 70%.

試験例1 実施例1及び比較例1で得られた組成物の服用感を10人のパネラーを用いて比較した。評価は以下のように5段階評価とした。
1:美味しい2:やや美味しい3:普通4:ややまずい5:まずい
Test Example 1 The ingestion feeling of the compositions obtained in Example 1 and Comparative Example 1 was compared using 10 panelists. Evaluation was made into five-step evaluation as follows.
1: Delicious 2: Slightly delicious 3: Normal 4: Slightly bad 5: Bad

Figure 0004124093
Figure 0004124093

また、比較例1についてはざらつきを感じるものがいた。
試験例2実施例1、比較例2及び3における製造適性を比較した。評価項目として、造粒性、組成物を2000g製造した際の造粒所要時間及び乾燥所要時間、粗大造粒物(18号篩で篩過した際の残存物)の発生率、を挙げた。
Moreover, about the comparative example 1, there exist some which feels rough.
Test Example 2 Production suitability in Example 1 and Comparative Examples 2 and 3 were compared. As evaluation items, granulation properties, time required for granulation and time required for drying when 2000 g of the composition were produced, and the rate of occurrence of coarse granules (residue when sieved with No. 18 sieve) were listed.

Figure 0004124093
Figure 0004124093

尚、比較例3では加温することでシロップの噴霧が可能となるが、その場合には粉体の濡れが悪く造粒が進行せず、結果的に微粉末が多く発生した。


In Comparative Example 3, the syrup can be sprayed by heating, but in this case, the wettability of the powder was poor and granulation did not proceed, and as a result, a lot of fine powder was generated.


Claims (1)

苦味や渋味を有する薬物、及び粉糖を含む粉体組成物を、砂糖濃度が50〜60%のシロップを用いて流動層造粒法で造粒することを特徴とする矯味経口製剤用組成物の製造方法。
A composition for a taste-masked oral preparation characterized by granulating a powder composition containing a drug having a bitter taste and astringency and a powdered sugar by a fluidized bed granulation method using a syrup having a sugar concentration of 50 to 60%. Manufacturing method.
JP2003360295A 2003-10-21 2003-10-21 Method for producing a composition for oral taste preparation Expired - Lifetime JP4124093B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003360295A JP4124093B2 (en) 2003-10-21 2003-10-21 Method for producing a composition for oral taste preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003360295A JP4124093B2 (en) 2003-10-21 2003-10-21 Method for producing a composition for oral taste preparation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP6206773A Division JPH0867623A (en) 1994-08-31 1994-08-31 Composition for taste masking oral preparation

Publications (2)

Publication Number Publication Date
JP2004083595A JP2004083595A (en) 2004-03-18
JP4124093B2 true JP4124093B2 (en) 2008-07-23

Family

ID=32064644

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003360295A Expired - Lifetime JP4124093B2 (en) 2003-10-21 2003-10-21 Method for producing a composition for oral taste preparation

Country Status (1)

Country Link
JP (1) JP4124093B2 (en)

Also Published As

Publication number Publication date
JP2004083595A (en) 2004-03-18

Similar Documents

Publication Publication Date Title
JP5537943B2 (en) Fast disintegrating solid preparation
JP6092936B2 (en) Method for producing orally disintegrating tablets
JP5097748B2 (en) Oral preparation
JPH0751504B2 (en) Vitamin granules for direct compression, production method and tablets
JP4300652B2 (en) Oral solid formulation
JP5421945B2 (en) Pharmaceutical composition containing irbesartan and amlodipine or a salt thereof
JP2006077018A (en) Orally disintegrating tablet
JPWO1999016470A1 (en) Oral dosage forms
PL194526B1 (en) Improved fast disintegrating tablet
HUP0202329A2 (en) Pharmaceutical composition in unit form containing acetylsalycilic acid and clopidogrel hydrogenosulphate
JPWO2007018192A1 (en) Orally disintegrating tablets
WO2022102457A1 (en) Linagliptin-containing orally disintegrating tablet
JPWO2003103713A1 (en) Quick disintegrating tablet and method for producing the same
JP5062872B2 (en) Orally disintegrating tablets with reduced unpleasant taste
JP2002029964A (en) Solid pharmaceutical composition
JP4124093B2 (en) Method for producing a composition for oral taste preparation
JP4400941B2 (en) Kampo-containing tablets, Kampo-filled capsules, herbal medicine-containing tablets, herbal medicine-filled capsules, manufacturing method of Kampo-containing tablets, herbal medicine-containing capsules, herbal medicine-containing tablets, and herbal medicine-filled capsules
JP7148319B2 (en) Orally disintegrating tablet containing prasugrel
JP2005132788A (en) Orally disintegrating tablets
JP2009137872A (en) Oral solid preparation containing glucuronolactone
JP4572296B2 (en) Pimobendan oral dosage formulation
KR20110007065A (en) Disintegrating tablet in oral cavity and manufacturing method thereof
JPH0867623A (en) Composition for taste masking oral preparation
JP3778240B2 (en) Granulated composition masked by unpleasant taste and method for producing the same
JP2002316930A (en) Granule, vitamin preparation, method for producing the same and method for stabilizing vitamin b12s

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070227

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080415

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080428

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110516

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110516

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120516

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120516

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130516

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130516

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140516

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term